Psychedelic Therapeutics Company Announces Submission of International Patents

Clearmind Medicine and SciSparc: A Leap Forward in Psychedelic-Based Therapeutics.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In an exciting development in the field of psychedelic-based therapeutics, Clearmind Medicine Inc. (Nasdaq: CMND) has announced the submission of three international patent applications. These novel patents pe…